Explore more publications!
Healthcare Times Denmark
Got News to Share?

Press Releases

Alveus Therapeutics Launches with $160 Million Series A Financing to Advance Next-Generation Therapies for Obesity and Metabolic Diseases
January 8, 2026

Alveus Therapeutics Launches with $160 Million Series A Financing to Advance Next-Generation Therapies for Obesity and Metabolic Diseases

Indeterminate GlobeNewswire, Inc.
Portuguese Brand Vcura Expands Globally with Clinically Inspired Wellness Innovation
January 7, 2026

Portuguese Brand Vcura Expands Globally with Clinically Inspired Wellness Innovation

Neutral EIN Presswire
Kimura Acupuncture, P.C. Now Offering AcuNova Acupuncture for Eye Health in Long Island, NY
January 7, 2026

Kimura Acupuncture, P.C. Now Offering AcuNova Acupuncture for Eye Health in Long Island, NY

Neutral EIN Presswire
Cell and Gene Therapy Third-Party Logistics Market Forecast From USD 1.81 Billion in 2025 to USD 16.95 Billion by 2035 Drives by Personalized Medicine Growth
January 7, 2026

Cell and Gene Therapy Third-Party Logistics Market Forecast From USD 1.81 Billion in 2025 to USD 16.95 Billion by 2035 Drives by Personalized Medicine Growth

Indeterminate GlobeNewswire, Inc.
AI in Behavioral Healthcare Market: A US$ 115.65 Billion Size by 2034 at a 7.69% CAGR
January 7, 2026

AI in Behavioral Healthcare Market: A US$ 115.65 Billion Size by 2034 at a 7.69% CAGR

Indeterminate GlobeNewswire, Inc.
NMD Pharma to present at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026

NMD Pharma to present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire, Inc.
SmileyWorld® and SKIDOS Unlock Emotional Learning Through Play
January 8, 2026

SmileyWorld® and SKIDOS Unlock Emotional Learning Through Play

Indeterminate GlobeNewswire, Inc.
Antag Therapeutics demonstrates compelling potential of its novel GIPR antagonist for obesity, reporting excellent tolerability in Phase 1 and enhanced weight loss in amylin combination study
January 8, 2026

Antag Therapeutics demonstrates compelling potential of its novel GIPR antagonist for obesity, reporting excellent tolerability in Phase 1 and enhanced weight loss in amylin combination study

Indeterminate GlobeNewswire, Inc.
Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities
January 8, 2026

Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities

Indeterminate GlobeNewswire, Inc.
Zealand Pharma to present at the J.P. Morgan Healthcare Conference
January 5, 2026

Zealand Pharma to present at the J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire, Inc.
Ascendis Pharma to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026

Ascendis Pharma to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire, Inc.
Why Respiratory Vaccines Remain a Strategic Focus for Healthcare Systems Worldwide?
January 5, 2026

Why Respiratory Vaccines Remain a Strategic Focus for Healthcare Systems Worldwide?

Indeterminate GlobeNewswire, Inc.
Maternal Nutrition Market Size to Surpass USD 70.36 Billion by 2035, Driven by Preventive Healthcare and AI-Led Innovation
January 5, 2026

Maternal Nutrition Market Size to Surpass USD 70.36 Billion by 2035, Driven by Preventive Healthcare and AI-Led Innovation

Indeterminate GlobeNewswire, Inc.
Weight Watchers Expands Its Integrated GLP-1 Platform with Access to Wegovy® Pill Advancing a New Standard for Long-Term Weight Health
January 5, 2026

Weight Watchers Expands Its Integrated GLP-1 Platform with Access to Wegovy® Pill Advancing a New Standard for Long-Term Weight Health

Indeterminate GlobeNewswire, Inc.
CDMO Aseptic Filling Solutions Market Solutions Guiding Informed Manufacturing and Outsourcing Decisions
January 8, 2026

CDMO Aseptic Filling Solutions Market Solutions Guiding Informed Manufacturing and Outsourcing Decisions

Indeterminate GlobeNewswire, Inc.
Danish Entrepreneur Shares 33-Year China Journey at Jiaxing Opening-Up Symposium
December 31, 2025

Danish Entrepreneur Shares 33-Year China Journey at Jiaxing Opening-Up Symposium

Indeterminate GlobeNewswire, Inc.
Bread Improvers Market Size to Exceed USD 2.92 Billion by 2035, Driven by Clean-Label, Functional Baking, and AI-Enabled Formulation
January 8, 2026

Bread Improvers Market Size to Exceed USD 2.92 Billion by 2035, Driven by Clean-Label, Functional Baking, and AI-Enabled Formulation

Indeterminate GlobeNewswire, Inc.
Total number of shares and voting rights in Zealand Pharma as of December 31, 2025
December 31, 2025

Total number of shares and voting rights in Zealand Pharma as of December 31, 2025

Indeterminate GlobeNewswire, Inc.
Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week
January 7, 2026

Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week

Indeterminate GlobeNewswire, Inc.
Functional Pet Food Market Size to Worth USD 7 Billion by 2035 | Towards FnB
January 7, 2026

Functional Pet Food Market Size to Worth USD 7 Billion by 2035 | Towards FnB

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions